8-KShareholder MattersCorporate ChangesExhibits & Filings

BIOGEN INC. 8-K Report, Bylaw Amendment (Jun 13, 2012)

Filed June 13, 2012For Securities:BIIB

Summary

Biogen Idec Inc. (BIIB) filed an 8-K report on June 13, 2012, detailing key outcomes from its Annual Meeting of Stockholders held on June 8, 2012. The most significant developments for investors involve changes to the company's corporate governance documents. Specifically, stockholders approved an amendment to the Certificate of Incorporation to designate Delaware as the exclusive forum for resolving derivative actions and certain other disputes. Additionally, an amendment to the Bylaws was approved, which now permits holders of at least 25% of the outstanding common stock to call a special meeting under specific circumstances. The report also provides the final voting results for various matters presented at the Annual Meeting. These include the election of twelve directors to the Board, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2012, and an advisory vote on executive compensation. The overwhelming majority of votes in favor of director elections and auditor ratification indicate strong shareholder confidence in the company's leadership and financial oversight.

Key Highlights

  • 1Biogen Idec Inc. stockholders approved amendments to the Certificate of Incorporation and Bylaws at the June 8, 2012 Annual Meeting.
  • 2The Charter Amendment designates Delaware as the exclusive forum for derivative actions and certain other shareholder disputes, aiming to streamline legal proceedings.
  • 3The Bylaw Amendment now allows shareholders holding at least 25% of outstanding common stock to call a special meeting under specific conditions, potentially increasing shareholder influence.
  • 4All twelve nominated directors were elected to the Board of Directors, indicating shareholder confidence in the current leadership.
  • 5PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for fiscal year 2012 with a strong majority vote.
  • 6The advisory vote on executive compensation received a favorable majority of votes, suggesting general approval of the company's compensation practices.

Frequently Asked Questions

This amendment aims to centralize litigation related to derivative actions and other specific corporate disputes within Delaware's established court system, which is well-versed in corporate law. This could lead to more predictable and potentially efficient resolution of such matters for Biogen Idec Inc.

The ability for a significant block of shareholders (25%) to call a special meeting provides a mechanism for them to address urgent matters outside of the regular annual meeting cycle, potentially enhancing shareholder activism and responsiveness on critical issues.

While the Charter Amendment to designate Delaware as the exclusive forum passed, there was a notable number of votes against it (81.8 million votes against vs. 134.6 million votes for). The Bylaw Amendment was passed with a much stronger majority. The advisory vote on executive compensation also received a considerable number of dissenting votes (2.6 million against).

All twelve nominees for the Board of Directors were elected to serve until the 2013 annual meeting. The 'Votes For' significantly outnumbered 'Votes Against' and 'Abstentions' for each nominee, indicating broad shareholder support for the Board's composition.